AN7-23953-76219
2 vaccinations
3 coded responses
8 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 725 / AR
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-02-20
Dose 2 — Moderna
-
2021-03-12
Registered in v-safe
-
2021-03-12
Survey response — day 14, dose 2MedDRA: Glomerular filtration rate decreased — Feeling: GoodFree text: On routine labs EGFR 10/20/20 67On routine labs EGFR 02/25/21. 56Have F/u to have rechecked 05/26/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
-
2021-05-24
Survey response — 3 months, dose 2MedDRA: Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Kidney function tests always normal prior to Moderna. Normal range EGFR >59, EGFR 12/20/20 67 #1 moderna 1/21/21 #2 Moderna 2/20/21 ,5days later 2/25/21 EGFR 56. Repeat EGFR 5/21/21 ; 56MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-25
-
2022-02-20
Survey response — 12 months, dose 2MedDRA: Blood creatinine decreased, Glomerular filtration rate increased, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: ModernaBooster 11/11/21 Labs 11/23/21 Bun range 6-20. My result 20 Creatinine range 0.4-1.0 1.0 Egfr > 60. 55.2 · Healthcare visit (other): Repeat labs scheduled for March 7, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-20 | Moderna |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — day 14, dose 2
Symptoms: On routine labs EGFR 10/20/20 67On routine labs EGFR 02/25/21. 56Have F/u to have rechecked 05/26/21
Release 8 — 3 months, dose 2
Symptoms: Kidney function tests always normal prior to Moderna. Normal range EGFR >59, EGFR 12/20/20 67 #1 moderna 1/21/21 #2 Moderna 2/20/21 ,5days later 2/25/21 EGFR 56. Repeat EGFR 5/21/21 ; 56
Release 11 — 12 months, dose 2
Symptoms: ModernaBooster 11/11/21 Labs 11/23/21 Bun range 6-20. My result 20 Creatinine range 0.4-1.0 1.0 Egfr > 60. 55.2
Healthcare visit (other): Repeat labs scheduled for March 7, 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Blood creatinine decreased | · | · | ✓ |
| SD | Glomerular filtration rate decreased | ✓ | ✓ | ✓ |
| SD | Glomerular filtration rate increased | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release